ExodusPoint Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-25,724
| Closed | -$493K | – | 1913 |
|
|
2024
Q4 | $493K | Buy |
+25,724
| New | +$493K | ﹤0.01% | 1055 |
|
|
2024
Q1 | – | Sell |
-58,903
| Closed | -$1.28M | – | 1874 |
|
|
2023
Q4 | $1.28M | Sell |
58,903
-115,718
| -66% | -$2.52M | 0.01% | 674 |
|
|
2023
Q3 | $2.68M | Sell |
174,621
-32,590
| -16% | -$500K | 0.03% | 550 |
|
|
2023
Q2 | $4.93M | Buy |
207,211
+80,310
| +63% | +$1.91M | 0.04% | 397 |
|
|
2023
Q1 | $3.23M | Sell |
126,901
-63,753
| -33% | -$1.62M | 0.03% | 602 |
|
|
2022
Q4 | $5.57M | Buy |
190,654
+81,686
| +75% | +$2.39M | 0.08% | 309 |
|
|
2022
Q3 | $2.24M | Buy |
+108,968
| New | +$2.24M | 0.03% | 724 |
|
|
2022
Q2 | – | Sell |
-97,745
| Closed | -$1.81M | – | 2423 |
|
|
2022
Q1 | $1.81M | Buy |
97,745
+20,988
| +27% | +$388K | 0.02% | 782 |
|
|
2021
Q4 | $1.52M | Buy |
+76,757
| New | +$1.52M | 0.02% | 839 |
|